3M's Drug Delivery Systems is a global leader in inhalation drug delivery with more than 60 million metered dose inhalers (MDIs) produced each year. 3M’s proven track record includes development of the first metered-dose inhaler (MDI) and the development of the first CFC-Free MDI. More than half of the MDIs manufactured worldwide utilize an MDI technology developed by 3M. We’ve built a solid global reputation in inhalation drug delivery systems over the past 50 years by providing:
- System development
- Hardware development – including dose counters and novel pMDI systems
- Valves and canister components
3M in-house resources are available to support each step of the development process from early stages through post-approval. In-house resources include pharmacokinetics, drug metabolism, clinical affairs, toxicology, analytical, regulatory affairs, quality assurance, operations and marketed product support.
We provide our inhalation partners extensive experience in regulatory affairs. Products developed by 3M have received regulatory approval in many countries, meeting rigorous standards, including those of the U.S. FDA.
